Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q2)Dec 31, 2025 | (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 57.23%72.69K | 47.64%87.49K | -19.39%237.67K | 0.01%82.63K | -6.68%49.55K | -16.58%46.23K | -42.87%59.26K | 73.38%294.86K | 46.79%82.63K | 117.83%53.09K |
| Operating revenue | 57.23%72.69K | 47.64%87.49K | -19.39%237.67K | 0.01%82.63K | -6.68%49.55K | -16.58%46.23K | -42.87%59.26K | 73.38%294.86K | 46.79%82.63K | 117.83%53.09K |
| Cost of revenue | 57.76%150.12K | 66.94%119.43K | -51.82%357.04K | -37.70%127.2K | -67.24%63.14K | -53.89%95.16K | -48.07%71.54K | 64.32%741.01K | 132.78%204.18K | 125.88%192.73K |
| Gross profit | -58.26%-77.42K | -159.99%-31.94K | 73.25%-119.36K | 63.34%-44.56K | 90.27%-13.59K | 67.58%-48.92K | 63.91%-12.29K | -58.83%-446.15K | -286.79%-121.55K | -129.11%-139.64K |
| Operating expense | 23.44%3.58M | 4.29%3.17M | -10.43%10.14M | 559.27%1.34M | -18.12%2.86M | -13.47%2.9M | -15.89%3.04M | -9.40%11.33M | -92.64%203.65K | -5.26%3.49M |
| Selling and administrative expenses | 21.33%2.65M | 8.64%2.45M | -19.25%8.96M | 6.45%2.39M | -22.33%2.13M | -21.51%2.18M | -27.26%2.26M | -12.86%11.1M | -42.89%2.25M | -14.97%2.75M |
| -Selling and marketing expense | 2,464.57%217.17K | 996.09%142.02K | 20.94%152.31K | 311.38%123.41K | -85.60%7.48K | --8.47K | --12.96K | 208.61%125.93K | --30K | --51.91K |
| -General and administrative expense | 11.81%2.43M | 2.94%2.31M | -19.71%8.81M | 2.33%2.27M | -21.11%2.12M | -21.82%2.17M | -27.68%2.24M | -13.57%10.97M | -43.06%2.22M | -16.58%2.69M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Depreciation amortization depletion | -12.06%361.41K | -11.89%351.54K | -7.61%1.83M | 2.94%602.82K | -19.91%414.14K | -17.60%410.99K | 6.11%398.97K | 71.14%1.98M | 71.54%585.59K | 61.25%517.06K |
| -Depreciation and amortization | -12.06%361.41K | -11.89%351.54K | -7.61%1.83M | 2.94%602.82K | -19.91%414.14K | -17.60%410.99K | 6.11%398.97K | 71.14%1.98M | 71.54%585.59K | 61.25%517.06K |
| Other operating expenses | 86.42%568.24K | -4.41%369.76K | 63.14%-644.95K | 37.17%-1.65M | 35.91%314.34K | 336.14%304.82K | 178.32%386.83K | -8.37%-1.75M | -51.88%-2.63M | 67.36%231.29K |
| Operating profit | -24.02%-3.66M | -4.91%-3.2M | 12.82%-10.26M | -326.56%-1.39M | 20.89%-2.87M | 15.80%-2.95M | 16.34%-3.05M | 7.90%-11.77M | 88.38%-325.21K | 3.07%-3.63M |
| Net non-operating interest income (expenses) | 382.64%65.78K | 202.94%25.02K | 45.08%-63.35K | 126.00%7.49K | 22.78%-23.26K | 16.45%-23.27K | 14.89%-24.3K | -11.56%-115.34K | -13.06%-28.81K | -7.31%-30.12K |
| Non-operating interest income | 219,930.56%79.21K | 754.41%43.28K | 401.87%32.14K | 2,401.88%25.24K | 136.99%1.79K | -95.24%36 | 30.51%5.07K | 817.48%6.4K | 100,800.00%1.01K | 1,545.65%757 |
| Non-operating interest expense | -40.69%11.94K | -37.83%18.26K | -21.57%95.49K | -12.80%35.13K | -32.70%17.78K | -27.05%20.13K | -9.46%29.37K | 16.97%121.74K | 22.63%40.29K | 2.75%26.42K |
| Total other finance cost | -53.15%1.49K | ---- | ---- | ---- | 63.26%7.27K | 214.14%3.18K | ---- | ---- | ---- | 85.77%4.45K |
| Other net income (expenses) | -2,424.02%-17.53M | -43.05%989.57K | -60.92%1.75M | -112.76%-1.88M | -20.00%1.14M | 15.33%754.45K | -33.85%1.74M | 25.97%4.49M | -159.93%-884.24K | 24.96%1.43M |
| Gain on sale of security | -16,576.14%-17.53M | -0.11%986.5K | -149.22%-731.2K | -37.51%-2.25M | -37.56%423.39K | -57.32%106.42K | -54.97%987.62K | -53.22%1.49M | -1,148.46%-1.64M | -55.33%678.07K |
| Other non-operating income (expenses) | -99.98%118 | -99.59%3.07K | -17.21%2.48M | -51.09%367.32K | -4.12%719.1K | 60.06%648.03K | 73.11%750.01K | 677.89%3M | -43.09%751.01K | 300.01%750K |
| Income before tax | -853.02%-21.12M | -63.29%-2.19M | -15.85%-8.57M | -163.35%-3.26M | 21.49%-1.76M | 22.89%-2.22M | -27.39%-1.34M | 20.62%-7.4M | 8.23%-1.24M | 15.13%-2.24M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -853.02%-21.12M | -63.29%-2.19M | -15.85%-8.57M | -163.35%-3.26M | 21.49%-1.76M | 22.89%-2.22M | -27.39%-1.34M | 20.62%-7.4M | 8.23%-1.24M | 15.13%-2.24M |
| Net income continuous operations | -853.02%-21.12M | -63.29%-2.19M | -15.85%-8.57M | -163.35%-3.26M | 21.49%-1.76M | 22.89%-2.22M | -27.39%-1.34M | 20.62%-7.4M | 8.23%-1.24M | 15.13%-2.24M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -853.02%-21.12M | -63.29%-2.19M | -15.85%-8.57M | -163.35%-3.26M | 21.49%-1.76M | 22.89%-2.22M | -27.39%-1.34M | 20.62%-7.4M | 8.23%-1.24M | 15.13%-2.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -853.02%-21.12M | -63.29%-2.19M | -15.85%-8.57M | -163.35%-3.26M | 21.49%-1.76M | 22.89%-2.22M | -27.39%-1.34M | 20.62%-7.4M | 8.23%-1.24M | 15.13%-2.24M |
| Diluted earnings per share | -679.48%-0.1785 | -40.71%-0.0197 | -0.69%-0.0871 | -147.73%-0.0327 | 33.71%-0.0175 | 32.65%-0.0229 | -10.24%-0.014 | 25.11%-0.0865 | 18.52%-0.0132 | 18.01%-0.0264 |
| Basic earnings per share | -679.48%-0.1785 | -40.71%-0.0197 | -0.69%-0.0871 | -147.73%-0.0327 | 33.71%-0.0175 | 32.65%-0.0229 | -10.24%-0.014 | 25.11%-0.0865 | 18.52%-0.0132 | 18.01%-0.0264 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.